SEC Form 4 · accession 0001354488-17-000114
Pharma-Bio Serv, Inc. · PBSV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Altura Victor Sanchez
Officer — President and CEO
Period of report
Jan 15, 2017
Accepted (ET)
Jan 18, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001304161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 15, 2017 | M | 8,350 | — | A | 49,211 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F2 | — | Jan 15, 2017 | M | 8,350 | D | — | — | Common Stock | 8,350 | 0 | D |
Explanation of responses
- F1Each restricted stock unit represents a contingent right to receive one share of Pharma-Bio Serv, Inc. common stock.
- F2The restricted stock units vested in three equal annual installments beginning on January 15, 2015.